Coordinated Care Management

September 18, 2012

Pathway Genetics and MD Revolution Join to Help People Manage Healthy Behaviors



Pathway Genomics Corporation, a San Diego-based clinical laboratory genetic testing company, has partnered with MD Revolution, which incorporates genomic and mobile health technologies into chronic disease management and prevention.

Founded by Samir Damani, MD, and Sunil Bhoyrul, MD, MD Revolution is the La Jolla-based medical practice of the doctors.

"We have enrolled over 50 patients into one of our programs,” said Damani. “Among patients that have completed the program, we found dramatic clinical and statistically significant improvements in at least one of four key health parameters including weight loss, visceral fat reduction, increases in metabolism and allowable daily caloric intake.”

Damani went on to note that patients in the trials improved blood pressure control and marked improvements in cardiorespiratory fitness.

MD Revolution said it helps patients by showing them how to better treat chronic conditions such as diabetes, which in this country currently affects 25.8 million children and adults, or 8.3 percent of the US population.

The company revealed at its website’s goal is to help people react pro-actively to their health by setting up preventive behaviors, rather than waiting till they get sick or injured to be treated.

The idea of personalized health – treatments and regimens tailored specifically to each patient – has been around for a while. IBM and Memorial Sloan-Kettering Cancer Center announced in March that they were joining together to develop a powerful tool to help improve the ability of healthcare providers to “personalize” treatments to cancer patients’ specific needs.

Since genes play such a huge role in disease, Pathway Genetics offers tests to people to find out their propensity for certain illnesses, which can then be looked for, or treated immediately, rather than waiting for the disease to develop. With breast cancer, there’s a test, called BRCA 1 and 2 that can detect certain mutations in genes that run in families, and 80 percent of the time result in the disease.  Some women choose to have pre-emptive surgery, appreciating the ability not to have to wait to get the disease and have lower chances of survival.




Edited by Brooke Neuman